Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells.
Sun, Bin; Hu, Congli; Yang, Zhibin; Zhang, Xiaofeng; Zhao, Linlin; Xiong, Junye; Ma, Junyong; Chen, Lei; Qian, Haihua; Luo, Xiangji; Shi, Lehua; Li, Jun; Cheng, Xianshuo; Yin, Zhengfeng.
; 8(20): 32523-32535, 2017 May 16.
Artigo em Inglês | MEDLINE | ID: mdl-28430645
Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinoma.
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival.
Evidence of CD90+CXCR4+ cells as circulating tumor stem cells in hepatocellular carcinoma.
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.
Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo.
Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma.
Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination.
Epithelial-mesenchymal transition in hepatocellular carcinoma.